Lv41
608 积分 2025-05-25 加入
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
30天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
2个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
2个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
3个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
5个月前
已关闭
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
5个月前
已完结
皖公网安备34019202002308
